⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | HSBC India Export Opportunities Fund - IDCW - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | HSBC MF | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹11.51 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Abhishek Gupta | Nikhil Mathur |
| Inception | 25 Sep 2024 | 04 Oct 2023 |
| Returns | ||
| 1Y | 13.67% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 7.30% | 29.15% |
| Risk | ||
| 15.95 | 14.07 | |
| 0.98 | 0.59 | |
| 0.32 | 1.59 | |
| 11.78 | 21.67 | |
| 0.59 | 3.48 | |
| -11.31% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.04% | 1.03% |
| Exit Load | Nil upto 10% of units and 1% for remaining units on or before 1Y, Nil after 1Y | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
HSBC MF92%
HDFC MF92%
8.2%Only 8.2% of holdings by weight are common between HSBC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingHSBC MFHDFC MF
Divi's Laboratories Ltd.3.86%9.39%
Torrent Pharmaceuticals Ltd.2.27%3.65%
Sun Pharmaceutical Industries Ltd.2.10%8.28%
Category context: Equity vs Equity. Open the full Screener →